Skip to main content
Clinical Trials/NCT00243711
NCT00243711
Completed
Phase 2

A Multi-Center Randomized Study to Evaluate the Efficacy and Safety of an Investigational Lubricant Eye Drop

Allergan0 sites286 target enrollmentSeptember 2005

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Dry Eye
Sponsor
Allergan
Enrollment
286
Primary Endpoint
Dry Eye Symptoms
Status
Completed
Last Updated
14 years ago

Overview

Brief Summary

The efficacy, safety and acceptability of an investigational lubricant eye drop in subjects with dry eye will be evaluated in comparison with currently-available lubricant eye drops.

Registry
clinicaltrials.gov
Start Date
September 2005
End Date
April 2006
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Allergan

Eligibility Criteria

Inclusion Criteria

  • Mild, Moderate, or Severe Dry Eye Symptoms and current eye drop use;
  • Reduced tear stability or tear production

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Dry Eye Symptoms

Secondary Outcomes

  • Ocular surface damage, tear stability, tear production

Similar Trials